Two Sigma Investments’s Regencell Bioscience RGC Stock Holding History
Bought
Maintained
Sold
Other funds holding RGC
Two Sigma Investments's RGC Position: Q3 2026 in Review
Two Sigma Investments sold out of Regencell Bioscience (RGC) in Q3 2026, closing a stake of 14,406 shares — an estimated $87.7K sold.
Two Sigma Investments first reported a position in RGC in Q2 2026 and held it in 1 quarter. The position peaked at $87.7K in Q2 2026. 31 funds tracked by Wall St. Rank hold RGC as of Q3 2026.
- Two Sigma Investments reported no remaining Regencell Bioscience position as of Q3 2026 after selling out during the quarter.
- Two Sigma Investments sold 14,406 Regencell Bioscience shares in Q3 2026, an estimated $87.7K.
- Two Sigma Investments first reported a position in Regencell Bioscience in Q2 2026 and held it in 1 quarter.
- Two Sigma Investments's Regencell Bioscience position peaked at $87.7K in Q2 2026.
- 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.